Related Experiment Videos
A three-hybrid system for detecting small ligand-protein receptor interactions
1Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139, USA.
Summary
A novel yeast three-hybrid system detects small molecule interactions with receptors in vivo. This genetic tool successfully identified human FKBP12, demonstrating its utility for discovering new drug targets and ligands.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Small molecule interactions with receptors are crucial for biological processes and drug development.
- Existing methods for detecting these interactions have limitations.
Purpose of the Study:
- To develop a novel genetic system, the yeast three-hybrid system, for detecting ligand-receptor interactions in vivo.
- To demonstrate the system's feasibility and utility in screening for receptors and ligands.
Main Methods:
- Adapted the yeast two-hybrid system by incorporating a synthetic hybrid ligand.
- Constructed fusion proteins involving the rat glucocorticoid receptor and FKBP12.
- Utilized a dexamethasone-FK506 heterodimer as the hybrid ligand.
- Screened a Jurkat cDNA library to identify interacting partners.
Main Results:
- The yeast three-hybrid system successfully detected ligand-receptor interactions in vivo.
- Reporter gene activation was observed with the dexamethasone-FK506 heterodimer and specific fusion proteins.
- Competitive inhibition confirmed the specificity of the interaction.
- The system identified overlapping clones of human FKBP12 from a cDNA library.
Conclusions:
- The yeast three-hybrid system is a feasible and effective tool for discovering receptors for small molecules.
- The system can be used to screen for new ligands that bind to known receptors.
- This technology has potential applications in drug discovery and understanding biological pathways.